➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
McKesson
Harvard Business School
Merck
Dow

Last Updated: October 20, 2021

DrugPatentWatch Database Preview

AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic drug sources for amoxicillin; omeprazole magnesium; rifabutin and what is the scope of freedom to operate?

Amoxicillin; omeprazole magnesium; rifabutin is the generic ingredient in one branded drug marketed by Redhill and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Amoxicillin; omeprazole magnesium; rifabutin has twenty-nine patent family members in twenty-four countries.

There are forty-six drug master file entries for amoxicillin; omeprazole magnesium; rifabutin. One supplier is listed for this compound.

Summary for AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN
International Patents:29
US Patents:4
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 46
Finished Product Suppliers / Packagers: 1
DailyMed Link:AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN at DailyMed
Pharmacology for AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

US Patents and Regulatory Information for AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Redhill TALICIA amoxicillin; omeprazole magnesium; rifabutin CAPSULE, DELAYED RELEASE;ORAL 213004-001 Nov 1, 2019 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial Y ⤷  Free Forever Trial
Redhill TALICIA amoxicillin; omeprazole magnesium; rifabutin CAPSULE, DELAYED RELEASE;ORAL 213004-001 Nov 1, 2019 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial Y ⤷  Free Forever Trial
Redhill TALICIA amoxicillin; omeprazole magnesium; rifabutin CAPSULE, DELAYED RELEASE;ORAL 213004-001 Nov 1, 2019 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial Y ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
McKesson
Harvard Business School
Merck
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.